354 related articles for article (PubMed ID: 24779680)
1. Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy.
Han MK; Tayob N; Murray S; Dransfield MT; Washko G; Scanlon PD; Criner GJ; Casaburi R; Connett J; Lazarus SC; Albert R; Woodruff P; Martinez FJ
Am J Respir Crit Care Med; 2014 Jun; 189(12):1503-8. PubMed ID: 24779680
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial.
Vermeersch K; Gabrovska M; Aumann J; Demedts IK; Corhay JL; Marchand E; Slabbynck H; Haenebalcke C; Haerens M; Hanon S; Jordens P; Peché R; Fremault A; Lauwerier T; Delporte A; Vandenberk B; Willems R; Everaerts S; Belmans A; Bogaerts K; Verleden GM; Troosters T; Ninane V; Brusselle GG; Janssens W
Am J Respir Crit Care Med; 2019 Oct; 200(7):857-868. PubMed ID: 31046405
[No Abstract] [Full Text] [Related]
4. Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease.
Naderi N; Assayag D; Mostafavi-Pour-Manshadi SM; Kaddaha Z; Joubert A; Ouellet I; Drouin I; Li PZ; Bourbeau J
Respir Med; 2018 May; 138():129-136. PubMed ID: 29724384
[TBL] [Abstract][Full Text] [Related]
5. Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo - a post-hoc analysis of the BACE randomized controlled trial.
Vermeersch K; Belmans A; Bogaerts K; Gyselinck I; Cardinaels N; Gabrovska M; Aumann J; Demedts IK; Corhay JL; Marchand E; Slabbynck H; Haenebalcke C; Vermeersch S; Verleden GM; Troosters T; Ninane V; Brusselle GG; Janssens W;
Respir Res; 2019 Oct; 20(1):237. PubMed ID: 31665017
[TBL] [Abstract][Full Text] [Related]
6. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
[TBL] [Abstract][Full Text] [Related]
7. A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
Castaldo RS; Celli BR; Gomez F; LaVallee N; Souhrada J; Hanrahan JP
Clin Ther; 2003 Feb; 25(2):542-57. PubMed ID: 12749513
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study.
Kunisaki KM; Niewoehner DE; Connett JE;
Am J Respir Crit Care Med; 2012 Feb; 185(3):286-90. PubMed ID: 22077070
[TBL] [Abstract][Full Text] [Related]
9. Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): study protocol for a randomised controlled trial.
Uzun S; Djamin RS; Kluytmans J; Van't Veer NE; Ermens AA; Pelle AJ; Mulder P; van der Eerden MM; Aerts J
Trials; 2012 Jun; 13():82. PubMed ID: 22682323
[TBL] [Abstract][Full Text] [Related]
10. Azithromycin for prevention of exacerbations of COPD.
Albert RK; Connett J; Bailey WC; Casaburi R; Cooper JA; Criner GJ; Curtis JL; Dransfield MT; Han MK; Lazarus SC; Make B; Marchetti N; Martinez FJ; Madinger NE; McEvoy C; Niewoehner DE; Porsasz J; Price CS; Reilly J; Scanlon PD; Sciurba FC; Scharf SM; Washko GR; Woodruff PG; Anthonisen NR;
N Engl J Med; 2011 Aug; 365(8):689-98. PubMed ID: 21864166
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori.
Ra SW; Sze MA; Lee EC; Tam S; Oh Y; Fishbane N; Criner GJ; Woodruff PG; Lazarus SC; Albert R; Connett JE; Han MK; Martinez FJ; Aaron SD; Reed RM; Man SFP; Sin DD;
Respir Res; 2017 May; 18(1):109. PubMed ID: 28558695
[TBL] [Abstract][Full Text] [Related]
12. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.
Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK
Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101
[TBL] [Abstract][Full Text] [Related]
13. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial.
Uzun S; Djamin RS; Kluytmans JA; Mulder PG; van't Veer NE; Ermens AA; Pelle AJ; Hoogsteden HC; Aerts JG; van der Eerden MM
Lancet Respir Med; 2014 May; 2(5):361-8. PubMed ID: 24746000
[TBL] [Abstract][Full Text] [Related]
14. Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations.
Pomares X; Montón C; Espasa M; Casabon J; Monsó E; Gallego M
Int J Chron Obstruct Pulmon Dis; 2011; 6():449-56. PubMed ID: 22003290
[TBL] [Abstract][Full Text] [Related]
15. Predictors of re-exacerbation after an index exacerbation of chronic obstructive pulmonary disease in the REDUCE randomised clinical trial.
Engel B; Schindler C; Leuppi JD; Rutishauser J
Swiss Med Wkly; 2017; 147():w14439. PubMed ID: 28634972
[TBL] [Abstract][Full Text] [Related]
16. In-hospital antibiotic use for severe chronic obstructive pulmonary disease exacerbations: a retrospective observational study.
Vanoverschelde A; Van Hoey C; Buyle F; Den Blauwen N; Depuydt P; Van Braeckel E; Lahousse L
BMC Pulm Med; 2023 Apr; 23(1):138. PubMed ID: 37098509
[TBL] [Abstract][Full Text] [Related]
17. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
Woods JA; Wheeler JS; Finch CK; Pinner NA
Int J Chron Obstruct Pulmon Dis; 2014; 9():421-30. PubMed ID: 24833897
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease.
Hernández Cordero AI; Yang CX; Li X; Milne S; Chen V; Hollander Z; Ng R; Criner GJ; Woodruff PG; Lazarus SC; Connett JE; Han MK; Martinez FJ; Reed RM; Man SFP; Leung JM; Sin DD
Respir Res; 2021 Dec; 22(1):316. PubMed ID: 34937547
[TBL] [Abstract][Full Text] [Related]
19. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
[TBL] [Abstract][Full Text] [Related]
20. A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.
Wilson R; Anzueto A; Miravitlles M; Arvis P; Faragó G; Haverstock D; Trajanovic M; Sethi S
Int J Chron Obstruct Pulmon Dis; 2011; 6():373-83. PubMed ID: 21760724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
